(ICUI) ICU Medical - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US44930G1076
ICUI: Infusion Devices, Vascular Access, IV Solutions, Pumps, Software
ICU Medical, Inc. is a leading developer, manufacturer, and distributor of medical devices focused on infusion therapy, vascular access, and critical care solutions. The companys product portfolio includes a wide range of devices designed to enhance patient care and safety. Their offerings encompass needle-free connectors, catheter patency devices, and closed-system transfer devices, which are crucial for preventing infections and ensuring safe handling of hazardous drugs. Additionally, ICU Medical provides IV therapy and irrigation solutions, as well as advanced medical equipment such as infusion pumps and medication management software.
The company serves a diverse customer base, including acute care hospitals, ambulatory clinics, and alternate site facilities like home healthcare providers. Their products are essential for various healthcare settings, supporting both inpatient and outpatient care. ICU Medical has established itself as a key player in the healthcare industry since its founding in 1984, with its headquarters in San Clemente, California.
Looking ahead, ICU Medicals stock (NASDAQ:ICUI) is expected to experience volatility within a defined range. The stock is currently below its 20-day and 50-day moving averages, indicating potential bearish momentum. The ATR of 7.99 suggests that price movements could fluctuate within a range of approximately 128.67 to 142.65 over the next three months. This forecast is based on technical indicators, which do not account for unforeseen market developments or fundamental changes in the companys performance.
Additional Sources for ICUI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ICUI Stock Overview
Market Cap in USD | 3,371m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Health Care Supplies |
IPO / Inception | 1992-03-31 |
ICUI Stock Ratings
Growth Rating | -31.1 |
Fundamental | 0.21 |
Dividend Rating | 0.05 |
Rel. Strength | 48 |
Analysts | 4.33/5 |
Fair Price Momentum | 128.64 USD |
Fair Price DCF | 106.48 USD |
ICUI Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 0.2% |
ICUI Growth Ratios
Growth Correlation 3m | -77.2% |
Growth Correlation 12m | 28.3% |
Growth Correlation 5y | -71.4% |
CAGR 5y | -6.55% |
CAGR/Max DD 5y | -0.10 |
Sharpe Ratio 12m | -0.24 |
Alpha | 33.16 |
Beta | 0.722 |
Volatility | 35.30% |
Current Volume | 482.7k |
Average Volume 20d | 265k |
As of May 09, 2025, the stock is trading at USD 142.87 with a total of 482,692 shares traded.
Over the past week, the price has changed by +4.31%, over one month by +6.64%, over three months by -10.58% and over the past year by +42.02%.
Neither. Based on ValueRay Fundamental Analyses, ICU Medical is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.21 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ICUI as of May 2025 is 128.64. This means that ICUI is currently overvalued and has a potential downside of -9.96%.
ICU Medical has received a consensus analysts rating of 4.33. Therefor, it is recommend to buy ICUI.
- Strong Buy: 3
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ICUI ICU Medical will be worth about 140.9 in May 2026. The stock is currently trading at 142.87. This means that the stock has a potential downside of -1.35%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 186.4 | 30.5% |
Analysts Target Price | 186.4 | 30.5% |
ValueRay Target Price | 140.9 | -1.4% |